ID   BNC2_HUMAN              Reviewed;        1099 AA.
AC   Q6ZN30; B1APG9; Q6T3A3; Q8NAR2; Q9H6J0; Q9NXV0;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   07-APR-2021, entry version 148.
DE   RecName: Full=Zinc finger protein basonuclin-2;
GN   Name=BNC2 {ECO:0000312|HGNC:HGNC:30988};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAD18545.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon {ECO:0000312|EMBL:BAA90908.1},
RC   Kidney epithelium {ECO:0000312|EMBL:BAB15269.1},
RC   Teratocarcinoma {ECO:0000312|EMBL:BAC03837.1}, and
RC   Tongue {ECO:0000312|EMBL:BAD18545.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAR99389.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 73-1099 (ISOFORM 1), SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=15081112; DOI=10.1016/j.ygeno.2003.11.009;
RA   Romano R.-A., Li H., Tummala R., Maul R., Sinha S.;
RT   "Identification of Basonuclin2, a DNA-binding zinc-finger protein expressed
RT   in germ tissues and skin keratinocytes.";
RL   Genomics 83:821-833(2004).
RN   [4] {ECO:0000305}
RP   PROBABLE FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=14988505; DOI=10.1073/pnas.0400268101;
RA   Vanhoutteghem A., Djian P.;
RT   "Basonuclin 2: an extremely conserved homolog of the zinc finger protein
RT   basonuclin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:3468-3473(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-561, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-277; LYS-396; LYS-416; LYS-421;
RP   LYS-641; LYS-894 AND LYS-919, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [7]
RP   INVOLVEMENT IN LUTO, VARIANTS LUTO ILE-158; GLN-346; 853-ARG--ASP-1099 DEL
RP   AND ARG-888, FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=31051115; DOI=10.1016/j.ajhg.2019.03.023;
RA   Kolvenbach C.M., Dworschak G.C., Frese S., Japp A.S., Schuster P.,
RA   Wenzlitschke N., Yilmaz O., Lopes F.M., Pryalukhin A., Schierbaum L.,
RA   van der Zanden L.F.M., Kause F., Schneider R., Taranta-Janusz K.,
RA   Szczepanska M., Pawlaczyk K., Newman W.G., Beaman G.M., Stuart H.M.,
RA   Cervellione R.M., Feitz W.F.J., van Rooij I.A.L.M., Schreuder M.F.,
RA   Steffens M., Weber S., Merz W.M., Feldkoetter M., Hoppe B., Thiele H.,
RA   Altmueller J., Berg C., Kristiansen G., Ludwig M., Reutter H., Woolf A.S.,
RA   Hildebrandt F., Grote P., Zaniew M., Odermatt B., Hilger A.C.;
RT   "Rare variants in BNC2 are implicated in autosomal-dominant congenital
RT   lower urinary-tract obstruction.";
RL   Am. J. Hum. Genet. 104:994-1006(2019).
CC   -!- FUNCTION: Probable transcription factor specific for skin
CC       keratinocytes. May play a role in the differentiation of spermatozoa
CC       and oocytes (PubMed:14988505). May also play an important role in early
CC       urinary-tract development (PubMed:31051115).
CC       {ECO:0000269|PubMed:14988505, ECO:0000269|PubMed:31051115}.
CC   -!- INTERACTION:
CC       Q6ZN30; P25800: LMO1; NbExp=3; IntAct=EBI-6115618, EBI-8639312;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15081112}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:15081112};
CC         IsoId=Q6ZN30-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q6ZN30-2; Sequence=VSP_051873, VSP_051874;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, uterus and small
CC       intestine, and weakly expressed in colon and prostate. Also expressed
CC       in skin, primary keratinocytes, immortalized keratinocytes, and HeLa
CC       and HEK293 cells. Not detected in blood, thymus, spleen or Hep-G2
CC       cells. {ECO:0000269|PubMed:14988505, ECO:0000269|PubMed:15081112}.
CC   -!- DEVELOPMENTAL STAGE: In a 7-week embryo, expressed in the urogenital
CC       sinus, the precursor of the bladder, and its outflow tract. The most
CC       prominent expression is in the primitive urothelium, and there is
CC       weaker expression in the surrounding mesenchyme. Expression also
CC       detected in the urothelium of the adult male urethra.
CC       {ECO:0000269|PubMed:31051115}.
CC   -!- DISEASE: Lower urinary tract obstruction, congenital (LUTO)
CC       [MIM:618612]: A disorder characterized by urinary bladder outflow
CC       obstruction, which can represent an anatomical blockage or a functional
CC       obstruction. The most common anatomical causes are posterior urethral
CC       valves at the level of the prostatic urethra, a lesion unique to males.
CC       Less common are anterior urethral valves, also called urethral atresia,
CC       that can occur in either sex. LUTO is an autosomal dominant disease
CC       with variable expression. {ECO:0000269|PubMed:31051115}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAR99389.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA90908.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15269.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC03837.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK000050; BAA90908.1; ALT_INIT; mRNA.
DR   EMBL; AK025882; BAB15269.1; ALT_INIT; mRNA.
DR   EMBL; AK092247; BAC03837.1; ALT_INIT; mRNA.
DR   EMBL; AK131398; BAD18545.1; -; mRNA.
DR   EMBL; AL449983; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL450003; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL450105; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY438376; AAR99389.1; ALT_INIT; mRNA.
DR   CCDS; CCDS6482.2; -. [Q6ZN30-1]
DR   RefSeq; NP_060107.3; NM_017637.5. [Q6ZN30-1]
DR   BioGRID; 120155; 7.
DR   IntAct; Q6ZN30; 4.
DR   STRING; 9606.ENSP00000370047; -.
DR   iPTMnet; Q6ZN30; -.
DR   PhosphoSitePlus; Q6ZN30; -.
DR   BioMuta; BNC2; -.
DR   DMDM; 74762393; -.
DR   EPD; Q6ZN30; -.
DR   MassIVE; Q6ZN30; -.
DR   MaxQB; Q6ZN30; -.
DR   PaxDb; Q6ZN30; -.
DR   PeptideAtlas; Q6ZN30; -.
DR   PRIDE; Q6ZN30; -.
DR   ProteomicsDB; 67969; -. [Q6ZN30-1]
DR   ProteomicsDB; 67970; -. [Q6ZN30-2]
DR   Antibodypedia; 10169; 79 antibodies.
DR   DNASU; 54796; -.
DR   Ensembl; ENST00000380672; ENSP00000370047; ENSG00000173068. [Q6ZN30-1]
DR   Ensembl; ENST00000484726; ENSP00000431516; ENSG00000173068. [Q6ZN30-2]
DR   GeneID; 54796; -.
DR   KEGG; hsa:54796; -.
DR   UCSC; uc003zml.4; human. [Q6ZN30-1]
DR   CTD; 54796; -.
DR   DisGeNET; 54796; -.
DR   GeneCards; BNC2; -.
DR   HGNC; HGNC:30988; BNC2.
DR   HPA; ENSG00000173068; Tissue enhanced (endometrium, ovary).
DR   MalaCards; BNC2; -.
DR   MIM; 608669; gene.
DR   MIM; 618612; phenotype.
DR   neXtProt; NX_Q6ZN30; -.
DR   OpenTargets; ENSG00000173068; -.
DR   Orphanet; 93110; Posterior urethral valve.
DR   PharmGKB; PA134953132; -.
DR   VEuPathDB; HostDB:ENSG00000173068.17; -.
DR   eggNOG; ENOG502QR8N; Eukaryota.
DR   GeneTree; ENSGT00390000005844; -.
DR   InParanoid; Q6ZN30; -.
DR   OMA; GTHFINP; -.
DR   OrthoDB; 96985at2759; -.
DR   PhylomeDB; Q6ZN30; -.
DR   TreeFam; TF350399; -.
DR   PathwayCommons; Q6ZN30; -.
DR   BioGRID-ORCS; 54796; 13 hits in 1013 CRISPR screens.
DR   ChiTaRS; BNC2; human.
DR   GeneWiki; BNC2; -.
DR   GenomeRNAi; 54796; -.
DR   Pharos; Q6ZN30; Tbio.
DR   PRO; PR:Q6ZN30; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q6ZN30; protein.
DR   Bgee; ENSG00000173068; Expressed in sural nerve and 209 other tissues.
DR   ExpressionAtlas; Q6ZN30; baseline and differential.
DR   Genevisible; Q6ZN30; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0003416; P:endochondral bone growth; IEA:Ensembl.
DR   GO; GO:0060485; P:mesenchyme development; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0060021; P:roof of mouth development; IEA:Ensembl.
DR   GO; GO:0043586; P:tongue development; IEA:Ensembl.
DR   InterPro; IPR040436; Disconnected-like.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR15021; PTHR15021; 1.
DR   Pfam; PF00096; zf-C2H2; 1.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Isopeptide bond; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1099
FT                   /note="Zinc finger protein basonuclin-2"
FT                   /id="PRO_0000046934"
FT   ZN_FING         441..464
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         833..856
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1035..1058
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1063..1090
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   COMPBIAS        534..614
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         561
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CROSSLNK        277
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        396
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        416
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        421
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        641
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        894
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        919
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         881..903
FT                   /note="HSANINLHRKLLTKELDDMGLDS -> YWEKSNEQNGLLVSWGETLSSLK
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_051873"
FT   VAR_SEQ         904..1099
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_051874"
FT   VARIANT         158
FT                   /note="T -> I (in LUTO; unknown pathological significance;
FT                   dbSNP:rs144242525)"
FT                   /evidence="ECO:0000269|PubMed:31051115"
FT                   /id="VAR_083492"
FT   VARIANT         346
FT                   /note="E -> Q (in LUTO; unknown pathological significance;
FT                   dbSNP:rs945575406)"
FT                   /evidence="ECO:0000269|PubMed:31051115"
FT                   /id="VAR_083493"
FT   VARIANT         550
FT                   /note="L -> V (in dbSNP:rs4961490)"
FT                   /id="VAR_052707"
FT   VARIANT         782
FT                   /note="T -> A (in dbSNP:rs3739714)"
FT                   /id="VAR_033543"
FT   VARIANT         853..1099
FT                   /note="Missing (in LUTO; dbSNP:rs1350162888)"
FT                   /evidence="ECO:0000269|PubMed:31051115"
FT                   /id="VAR_083494"
FT   VARIANT         888
FT                   /note="H -> R (in LUTO; dbSNP:rs1563774686)"
FT                   /evidence="ECO:0000269|PubMed:31051115"
FT                   /id="VAR_083495"
FT   CONFLICT        560
FT                   /note="F -> L (in Ref. 1; BAC03837)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        630
FT                   /note="K -> T (in Ref. 1; BAC03837)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        797
FT                   /note="G -> E (in Ref. 1; BAB15269)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1099 AA;  122330 MW;  B1601EACD158D3D3 CRC64;
     MAHLGPTPPP HSLNYKSEDR LSEQDWPAYF KVPCCGVDTS QIESEEAEVD VRERETQRDR
     EPKRARDLTL RDSCTDNSMQ FGTRTTTAEP GFMGTWQNAD TNLLFRMSQQ AIRCTLVNCT
     CECFQPGKIN LRTCDQCKHG WVAHALDKLS TQHLYHPTQV EIVQSNVVFD ISSLMLYGTQ
     AVPVRLKILL DRLFSVLKQE EVLHILHGLG WTLRDYVRGY ILQDAAGKVL DRWAIMSREE
     EIITLQQFLR FGETKSIVEL MAIQEKEGQA VAVPSSKTDS DIRTFIESNN RTRSPSLLAH
     LENSNPSSIH HFENIPNSLA FLLPFQYINP VSAPLLGLPP NGLLLEQPGL RLREPSLSTQ
     NEYNESSESE VSPTPYKNDQ TPNRNALTSI TNVEPKTEPA CVSPIQNSAP VSDLTKTEHP
     KSSFRIHRMR RMGSASRKGR VFCNACGKTF YDKGTLKIHY NAVHLKIKHR CTIEGCNMVF
     SSLRSRNRHS ANPNPRLHMP MLRNNRDKDL IRATSGAATP VIASTKSNLA LTSPGRPPMG
     FTTPPLDPVL QNPLPSQLVF SGLKTVQPVP PFYRSLLTPG EMVSPPTSLP TSPIIPTSGT
     IEQHPPPPSE PVVPAVMMAT HEPSADLAPK KKPRKSSMPV KIEKEIIDTA DEFDDEDDDP
     NDGGAVVNDM SHDNHCHSQE EMSPGMSVKD FSKHNRTRCI SRTEIRRADS MTSEDQEPER
     DYENESESSE PKLGEESMEG DEHIHSEVSE KVLMNSERPD ENHSEPSHQD VIKVKEEFTD
     PTYDMFYMSQ YGLYNGGGAS MAALHESFTS SLNYGSPQKF SPEGDLCSSP DPKICYVCKK
     SFKSSYSVKL HYRNVHLKEM HVCTVAGCNA AFPSRRSRDR HSANINLHRK LLTKELDDMG
     LDSSQPSLSK DLRDEFLVKI YGAQHPMGLD VREDASSPAG TEDSHLNGYG RGMAEDYMVL
     DLSTTSSLQS SSSIHSSRES DAGSDEGILL DDIDGASDSG ESAHKAEAPA LPGSLGAEVS
     GSLMFSSLSG SNGGIMCNIC HKMYSNKGTL RVHYKTVHLR EMHKCKVPGC NMMFSSVRSR
     NRHSQNPNLH KNIPFTSVD
//
